Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP625014.RAWYKV7P9ras0t35cmQj3JTax_gvHcZj5O1h-pJqTr2WY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP625014.RAWYKV7P9ras0t35cmQj3JTax_gvHcZj5O1h-pJqTr2WY130_assertion type Assertion NP625014.RAWYKV7P9ras0t35cmQj3JTax_gvHcZj5O1h-pJqTr2WY130_head.
- NP625014.RAWYKV7P9ras0t35cmQj3JTax_gvHcZj5O1h-pJqTr2WY130_assertion description "[We tested the effect of pan-class I PI3K inhibition by siRNA silencing or pharmacologic inhibition with buparlisib on MM cell survival, apoptosis and cell cycle in vitro and tumor growth and mobilization of MM cells in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625014.RAWYKV7P9ras0t35cmQj3JTax_gvHcZj5O1h-pJqTr2WY130_provenance.
- NP625014.RAWYKV7P9ras0t35cmQj3JTax_gvHcZj5O1h-pJqTr2WY130_assertion evidence source_evidence_literature NP625014.RAWYKV7P9ras0t35cmQj3JTax_gvHcZj5O1h-pJqTr2WY130_provenance.
- NP625014.RAWYKV7P9ras0t35cmQj3JTax_gvHcZj5O1h-pJqTr2WY130_assertion SIO_000772 25060991 NP625014.RAWYKV7P9ras0t35cmQj3JTax_gvHcZj5O1h-pJqTr2WY130_provenance.
- NP625014.RAWYKV7P9ras0t35cmQj3JTax_gvHcZj5O1h-pJqTr2WY130_assertion wasDerivedFrom befree-20150227 NP625014.RAWYKV7P9ras0t35cmQj3JTax_gvHcZj5O1h-pJqTr2WY130_provenance.
- NP625014.RAWYKV7P9ras0t35cmQj3JTax_gvHcZj5O1h-pJqTr2WY130_assertion wasGeneratedBy ECO_0000203 NP625014.RAWYKV7P9ras0t35cmQj3JTax_gvHcZj5O1h-pJqTr2WY130_provenance.